Align Technology Inc(ALGN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 26.41 | EPS (ttm) | 5.76 | Insider Own | 3.32% | Shs Outstand | 71.3M | Perf Week | 2.19% |
| Market Cap | 10.82B | Forward P/E | 12.33 | EPS next Y | 10.12% | Insider Trans | - | Shs Float | 68.7M | Perf Month | 3.73% |
| Enterprise Value | 9.83B | PEG | 1.43 | EPS next Q | 2.77 | Inst Own | 105.39% | Short Float | 6.12% | Perf Quarter | -13.29% |
| Income | 0.41B | P/S | 2.61 | EPS this Y | 6.7% | Inst Trans | 3.66% | Short Ratio | 4.51 | Perf Half Y | -17.56% |
| Sales | 4.14B | P/B | 2.56 | EPS next 5Y | 8.63% | ROA | 6.55% | Short Interest | 4.20M | Perf YTD | -2.49% |
| Book/sh | 59.41 | P/C | 9.81 | EPS past 3/5Y | 7.03% -24.08% | ROE | 10.16% | 52W High | -24.04% ($200.43) | Perf Year | 12.61% |
| Cash/sh | 15.52 | P/FCF | 17.07 | Sales past 3/5Y | 2.61% 10.3% | ROIC | 9.58% | 52W Low | 16.92% ($130.23) | Perf 3Y | -20.1% |
| Dividend Est. | - | EV/EBITDA | 10.38 | EPS Y/Y TTM | -2.69% | Gross Margin | 70.65% | Volatility(W/M) | 2.45% 2.59% | Perf 5Y | -74.34% |
| Dividend TTM | - | EV/Sales | 2.38 | Sales Y/Y TTM | 4.41% | Oper. Margin | 18.38% | ATR (14) | 4.2 | Perf 10Y | 80.15% |
| Dividend Ex-Date | - | Quick Ratio | 1.28 | EPS Q/Q | -11.79% | Profit Margin | 9.99% | RSI (14) | 55.46 | Recom | 2.26 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.4 | Sales Q/Q | 4.32% | SMA20 | 4.2% ($146.12) | Beta | 1.74 | Target Price | $188.38 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 2026/10/28 | SMA50 | 0.51% ($151.49) | Rel Volume | 1.01 | Prev Close | $154.51 |
| Employees | 20290 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 0.91% 0.4% | SMA200 | -10.01% ($169.2) | Avg Volume(3M) | 0.93M | Price | $152.26 |
| IPO | 2001/1/26 | Option/Short | Yes/Yes | Trades | 15360 | Volume | 942,379 | Change | -1.46% |
A US dental medical device company that develops and supplies clear aligners (Invisalign) and intraoral scanners, digitizing the orthodontic market as a global clear aligner and digital dental solutions company, and a pioneer in the clear aligner field.
Over the past 1 year, roughly in the middle
24% below its 1-year high.
Traded about as much as usual. That is 101% of its average volume.
Next earnings report: October 28
1 days to go.
ALGN makes money exceptionally well
Of every $100 in sales, $18.38 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +6.7% this year.
Tap to view numbers
Within its industry, it looks cheap
Counting its debt, for $100 of yearly operating cash you would pay $1,038. Peers typically go for $1,583. Compared with its own 5-year average, it is 28% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -74.3%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 105.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #12 of 51 in the industry
Based on market cap of $11B.
FAQ
What kind of company is ALGN?
ALGN belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ALGN?
The market cap of ALGN is approximately $10.8B, ranking 869 within its sector.
What is the P/E ratio of ALGN?
ALGN has a P/E ratio of approximately 26.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ALGN?
ALGN has recorded a 52-week high of $200.43 and a low of $130.23.